Back
Results - Announcements
Sales decline 9.72% to Rs 115.14 crore
Syncom Formulations (India) consolidated net profit rises 45.46% in the December 2025 quarter
12-Feb-2026, 06:20
Net profit of Syncom Formulations (India) rose 45.46% to Rs 18.91 crore in the quarter ended December 2025 as against Rs 13.00 crore during the previous quarter ended December 2024. Sales declined 9.72% to Rs 115.14 crore in the quarter ended December 2025 as against Rs 127.53 crore during the previous quarter ended December 2024.
Net profit of Syncom Formulations (India) rose 45.46% to Rs 18.91 crore in the quarter ended December 2025 as against Rs 13.00 crore during the previous quarter ended December 2024. Sales declined 9.72% to Rs 115.14 crore in the quarter ended December 2025 as against Rs 127.53 crore during the previous quarter ended December 2024.
| Particulars | Quarter Ended | ||
| Dec. 2025 | Dec. 2024 | % Var. | |
| Sales | 115.14 | 127.53 | -10 |
| OPM % | 18.42 | 11.55 | - |
| PBDT | 26.45 | 18.57 | 42 |
| PBT | 25.09 | 17.26 | 45 |
| NP | 18.91 | 13.00 | 45 |
Powered by Capital Market - Live News